Global Blood Product Market Growth (Status and Outlook) 2024-2030

2024

Global Blood Product Market Growth (Status and Outlook) 2024-2030

Name: Global Blood Product Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Blood Product market grows from US$27.70 billion in 2023 to US$47.12 billion by 2030, with a 7.9% CAGR, due to increasing demand in the downstream market.

Bonafide Trust
04-01-2024
Pages : 151
Figures : 87
Tables : 152
Region : Global
Category : Lifescience
Healthcare

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

Blood products play a vital role in modern medicine, serving as a cornerstone of various medical procedures and treatments. These products are derived from whole blood donations and meticulously processed to isolate specific components with unique therapeutic properties. Whole blood itself is a complex biological fluid composed of several key elements:
• Red blood cells (RBCs): These microscopic, disc-shaped cells are the workhorses of the circulatory system. Packed with hemoglobin, an iron-rich protein, RBCs are responsible for transporting oxygen from the lungs to tissues throughout the body. A deficiency in healthy RBCs leads to anemia, a condition characterized by fatigue, weakness, and shortness of breath.
• Plasma: The liquid portion of blood, plasma constitutes about 55% of whole blood volume. It's a straw-colored fluid that serves as a transport medium for various substances

According to our publisher’s latest study, the global Blood Product market size was valued at US$ 27700 million in 2023. With growing demand in downstream market, the Blood Product is forecast to a readjusted size of US$ 47120 million by 2030 with a CAGR of 7.9% during review period.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The research report highlights the growth potential of the global Blood Product market. Blood Product are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Blood Product. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Blood Product market.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Key Features:

The report on Blood Product market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Blood Product market. It may include historical data, market segmentation by Type (e.g., Albumin, Immunoglobulin), and regional breakdowns.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Blood Product market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Blood Products Market Dynamics: A Balancing Act
The global blood product market is a vital but complex ecosystem driven by increasing demand and ongoing challenges.
Market Drivers:
• Rising Healthcare Needs: Growing prevalence of chronic diseases like cancer and an aging population elevate the need for blood products in treatment and surgeries.
• Technological Advancements: Innovations in blood processing and storage techniques enhance the safety, efficacy, and availability of blood products.
Market Trends:
• Blood Shortage Concerns: The global demand for blood products often outpaces the readily available supply, especially in developing regions.
• Focus on Plasma Derivatives: Expanding the therapeutic applications for plasma derivatives, like antibodies, creates new market avenues.
Market Challenges:
• Safety Regulations: Stringent regulations and thorough testing are crucial to minimize the risk of transfusion-transmitted infections.
• Cost Considerations: High costs associated with development, manufacturing, and storage of blood products can limit accessibility in some areas.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Blood Product market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Blood Product industry. This include advancements in Blood Product technology, Blood Product new entrants, Blood Product new investment, and other innovations that are shaping the future of Blood Product.
• Automated Blood Collection Systems: These systems streamline blood donation by automating blood volume measurement and component separation, improving efficiency and donor comfort.
• Advanced Blood Component Separation Techniques: New technologies like centrifugation with improved control systems ensure more efficient and precise separation of red blood cells, plasma, and platelets from whole blood, minimizing product loss and waste.
• Pathogen Reduction Systems: These innovative techniques utilize ultraviolet light or other methods to further inactivate potential pathogens in blood products, enhancing safety and reducing the risk of transfusion-transmitted infections.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Blood Product market. It includes factors influencing customer ' purchasing decisions, preferences for Blood Product product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Blood Product market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Blood Product market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Blood Product market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Blood Product industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
• Rising Demand: Increasing prevalence of chronic diseases, aging population, and trauma cases will fuel demand for blood transfusions and therapies.
• Technological Advancements: Innovations in blood collection, processing, and storage enhance safety, efficacy, and availability.
• Emerging Market Focus: Government initiatives in developing economies promote blood donation awareness and improve blood bank infrastructure.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Blood Product market.
• Combating Chronic Diseases: Rising prevalence of chronic illnesses like cancer and hemophilia fuels demand for blood products in treatment regimens.
• Aging Advantage: An aging population increases the need for blood products in surgeries and treatments for age-related conditions.
• Technological Triumphs: Advancements in blood processing and storage techniques enhance the availability and efficacy of blood products.

Market Segmentation:

Blood Product market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

Albumin

Immunoglobulin

Clotting Factor

Others

Segmentation by application

Bleeding Wound

Immunodeficiency

HBV

Tetanus

Rabies

Hemophilia

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co., Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Blood Product Market Size 2019-2030
2.1.2 Blood Product Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Blood Product Segment by Type
2.2.1 Albumin
2.2.2 Immunoglobulin
2.2.3 Clotting Factor
2.2.4 Others
2.3 Blood Product Market Size by Type
2.3.1 Blood Product Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Blood Product Market Size Market Share by Type (2019-2024)
2.4 Blood Product Segment by Application
2.4.1 Bleeding Wound
2.4.2 Immunodeficiency
2.4.3 HBV
2.4.4 Tetanus
2.4.5 Rabies
2.4.6 Hemophilia
2.4.7 Others
2.5 Blood Product Market Size by Application
2.5.1 Blood Product Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Blood Product Market Size Market Share by Application (2019-2024)
3 Blood Product Market Size by Player
3.1 Blood Product Market Size Market Share by Players
3.1.1 Global Blood Product Revenue by Players (2019-2024)
3.1.2 Global Blood Product Revenue Market Share by Players (2019-2024)
3.2 Global Blood Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Blood Product by Regions
4.1 Blood Product Market Size by Regions (2019-2024)
4.2 Americas Blood Product Market Size Growth (2019-2024)
4.3 APAC Blood Product Market Size Growth (2019-2024)
4.4 Europe Blood Product Market Size Growth (2019-2024)
4.5 Middle East & Africa Blood Product Market Size Growth (2019-2024)
5 Americas
5.1 Americas Blood Product Market Size by Country (2019-2024)
5.2 Americas Blood Product Market Size by Type (2019-2024)
5.3 Americas Blood Product Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Product Market Size by Region (2019-2024)
6.2 APAC Blood Product Market Size by Type (2019-2024)
6.3 APAC Blood Product Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Blood Product by Country (2019-2024)
7.2 Europe Blood Product Market Size by Type (2019-2024)
7.3 Europe Blood Product Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blood Product by Region (2019-2024)
8.2 Middle East & Africa Blood Product Market Size by Type (2019-2024)
8.3 Middle East & Africa Blood Product Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Blood Product Market Forecast
10.1 Global Blood Product Forecast by Regions (2025-2030)
10.1.1 Global Blood Product Forecast by Regions (2025-2030)
10.1.2 Americas Blood Product Forecast
10.1.3 APAC Blood Product Forecast
10.1.4 Europe Blood Product Forecast
10.1.5 Middle East & Africa Blood Product Forecast
10.2 Americas Blood Product Forecast by Country (2025-2030)
10.2.1 United States Blood Product Market Forecast
10.2.2 Canada Blood Product Market Forecast
10.2.3 Mexico Blood Product Market Forecast
10.2.4 Brazil Blood Product Market Forecast
10.3 APAC Blood Product Forecast by Region (2025-2030)
10.3.1 China Blood Product Market Forecast
10.3.2 Japan Blood Product Market Forecast
10.3.3 Korea Blood Product Market Forecast
10.3.4 Southeast Asia Blood Product Market Forecast
10.3.5 India Blood Product Market Forecast
10.3.6 Australia Blood Product Market Forecast
10.4 Europe Blood Product Forecast by Country (2025-2030)
10.4.1 Germany Blood Product Market Forecast
10.4.2 France Blood Product Market Forecast
10.4.3 UK Blood Product Market Forecast
10.4.4 Italy Blood Product Market Forecast
10.4.5 Russia Blood Product Market Forecast
10.5 Middle East & Africa Blood Product Forecast by Region (2025-2030)
10.5.1 Egypt Blood Product Market Forecast
10.5.2 South Africa Blood Product Market Forecast
10.5.3 Israel Blood Product Market Forecast
10.5.4 Turkey Blood Product Market Forecast
10.5.5 GCC Countries Blood Product Market Forecast
10.6 Global Blood Product Forecast by Type (2025-2030)
10.7 Global Blood Product Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Blood Product Product Offered
11.1.3 Takeda Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Blood Product Product Offered
11.2.3 CSL Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Blood Product Product Offered
11.3.3 Grifols Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Grifols Main Business Overview
11.3.5 Grifols Latest Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Blood Product Product Offered
11.4.3 Octapharma Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Octapharma Main Business Overview
11.4.5 Octapharma Latest Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Blood Product Product Offered
11.5.3 Kedrion Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Kedrion Main Business Overview
11.5.5 Kedrion Latest Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Blood Product Product Offered
11.6.3 LFB Group Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 LFB Group Main Business Overview
11.6.5 LFB Group Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Blood Product Product Offered
11.7.3 Biotest Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Blood Product Product Offered
11.8.3 BPL Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 BPL Main Business Overview
11.8.5 BPL Latest Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Blood Product Product Offered
11.9.3 Shanghai RAAS Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Shanghai RAAS Main Business Overview
11.9.5 Shanghai RAAS Latest Developments
11.10 China Biologic Products
11.10.1 China Biologic Products Company Information
11.10.2 China Biologic Products Blood Product Product Offered
11.10.3 China Biologic Products Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 China Biologic Products Main Business Overview
11.10.5 China Biologic Products Latest Developments
11.11 Hualan Biological Engineering Inc.
11.11.1 Hualan Biological Engineering Inc. Company Information
11.11.2 Hualan Biological Engineering Inc. Blood Product Product Offered
11.11.3 Hualan Biological Engineering Inc. Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Hualan Biological Engineering Inc. Main Business Overview
11.11.5 Hualan Biological Engineering Inc. Latest Developments
11.12 Beijing Tiantan Biological Products Corp
11.12.1 Beijing Tiantan Biological Products Corp Company Information
11.12.2 Beijing Tiantan Biological Products Corp Blood Product Product Offered
11.12.3 Beijing Tiantan Biological Products Corp Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beijing Tiantan Biological Products Corp Main Business Overview
11.12.5 Beijing Tiantan Biological Products Corp Latest Developments
11.13 Pacific Shuanglin
11.13.1 Pacific Shuanglin Company Information
11.13.2 Pacific Shuanglin Blood Product Product Offered
11.13.3 Pacific Shuanglin Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Pacific Shuanglin Main Business Overview
11.13.5 Pacific Shuanglin Latest Developments
11.14 Boya Bio-Pharmaceutical
11.14.1 Boya Bio-Pharmaceutical Company Information
11.14.2 Boya Bio-Pharmaceutical Blood Product Product Offered
11.14.3 Boya Bio-Pharmaceutical Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Boya Bio-Pharmaceutical Main Business Overview
11.14.5 Boya Bio-Pharmaceutical Latest Developments
11.15 Paisi Feike Biology Pharmacy Co., Ltd.
11.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Company Information
11.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Offered
11.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Main Business Overview
11.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
11.16 Xinjiang Deyuan Bioengineering
11.16.1 Xinjiang Deyuan Bioengineering Company Information
11.16.2 Xinjiang Deyuan Bioengineering Blood Product Product Offered
11.16.3 Xinjiang Deyuan Bioengineering Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Xinjiang Deyuan Bioengineering Main Business Overview
11.16.5 Xinjiang Deyuan Bioengineering Latest Developments
11.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
11.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
11.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Offered
11.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business Overview
11.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
11.18 Shenzhen Weiguang
11.18.1 Shenzhen Weiguang Company Information
11.18.2 Shenzhen Weiguang Blood Product Product Offered
11.18.3 Shenzhen Weiguang Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Shenzhen Weiguang Main Business Overview
11.18.5 Shenzhen Weiguang Latest Developments
11.19 Shanxi Kangbao
11.19.1 Shanxi Kangbao Company Information
11.19.2 Shanxi Kangbao Blood Product Product Offered
11.19.3 Shanxi Kangbao Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Shanxi Kangbao Main Business Overview
11.19.5 Shanxi Kangbao Latest Developments
11.20 Nanyue Biopharming Corporation Ltd
11.20.1 Nanyue Biopharming Corporation Ltd Company Information
11.20.2 Nanyue Biopharming Corporation Ltd Blood Product Product Offered
11.20.3 Nanyue Biopharming Corporation Ltd Blood Product Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Nanyue Biopharming Corporation Ltd Main Business Overview
11.20.5 Nanyue Biopharming Corporation Ltd Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Blood Product Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Albumin
Table 3. Major Players of Immunoglobulin
Table 4. Major Players of Clotting Factor
Table 5. Major Players of Others
Table 6. Blood Product Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Blood Product Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Blood Product Market Size Market Share by Type (2019-2024)
Table 9. Blood Product Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Blood Product Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Blood Product Market Size Market Share by Application (2019-2024)
Table 12. Global Blood Product Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Blood Product Revenue Market Share by Player (2019-2024)
Table 14. Blood Product Key Players Head office and Products Offered
Table 15. Blood Product Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Blood Product Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Blood Product Market Size Market Share by Regions (2019-2024)
Table 20. Global Blood Product Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Blood Product Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Blood Product Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Blood Product Market Size Market Share by Country (2019-2024)
Table 24. Americas Blood Product Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Blood Product Market Size Market Share by Type (2019-2024)
Table 26. Americas Blood Product Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Blood Product Market Size Market Share by Application (2019-2024)
Table 28. APAC Blood Product Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Blood Product Market Size Market Share by Region (2019-2024)
Table 30. APAC Blood Product Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Blood Product Market Size Market Share by Type (2019-2024)
Table 32. APAC Blood Product Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Blood Product Market Size Market Share by Application (2019-2024)
Table 34. Europe Blood Product Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Blood Product Market Size Market Share by Country (2019-2024)
Table 36. Europe Blood Product Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Blood Product Market Size Market Share by Type (2019-2024)
Table 38. Europe Blood Product Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Blood Product Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Blood Product Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Blood Product Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Blood Product Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Blood Product Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Blood Product Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Blood Product Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Blood Product
Table 47. Key Market Challenges & Risks of Blood Product
Table 48. Key Industry Trends of Blood Product
Table 49. Global Blood Product Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Blood Product Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Blood Product Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Blood Product Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Takeda Details, Company Type, Blood Product Area Served and Its Competitors
Table 54. Takeda Blood Product Product Offered
Table 55. Takeda Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Takeda Main Business
Table 57. Takeda Latest Developments
Table 58. CSL Details, Company Type, Blood Product Area Served and Its Competitors
Table 59. CSL Blood Product Product Offered
Table 60. CSL Main Business
Table 61. CSL Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. CSL Latest Developments
Table 63. Grifols Details, Company Type, Blood Product Area Served and Its Competitors
Table 64. Grifols Blood Product Product Offered
Table 65. Grifols Main Business
Table 66. Grifols Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Grifols Latest Developments
Table 68. Octapharma Details, Company Type, Blood Product Area Served and Its Competitors
Table 69. Octapharma Blood Product Product Offered
Table 70. Octapharma Main Business
Table 71. Octapharma Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Octapharma Latest Developments
Table 73. Kedrion Details, Company Type, Blood Product Area Served and Its Competitors
Table 74. Kedrion Blood Product Product Offered
Table 75. Kedrion Main Business
Table 76. Kedrion Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Kedrion Latest Developments
Table 78. LFB Group Details, Company Type, Blood Product Area Served and Its Competitors
Table 79. LFB Group Blood Product Product Offered
Table 80. LFB Group Main Business
Table 81. LFB Group Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. LFB Group Latest Developments
Table 83. Biotest Details, Company Type, Blood Product Area Served and Its Competitors
Table 84. Biotest Blood Product Product Offered
Table 85. Biotest Main Business
Table 86. Biotest Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Biotest Latest Developments
Table 88. BPL Details, Company Type, Blood Product Area Served and Its Competitors
Table 89. BPL Blood Product Product Offered
Table 90. BPL Main Business
Table 91. BPL Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. BPL Latest Developments
Table 93. Shanghai RAAS Details, Company Type, Blood Product Area Served and Its Competitors
Table 94. Shanghai RAAS Blood Product Product Offered
Table 95. Shanghai RAAS Main Business
Table 96. Shanghai RAAS Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Shanghai RAAS Latest Developments
Table 98. China Biologic Products Details, Company Type, Blood Product Area Served and Its Competitors
Table 99. China Biologic Products Blood Product Product Offered
Table 100. China Biologic Products Main Business
Table 101. China Biologic Products Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. China Biologic Products Latest Developments
Table 103. Hualan Biological Engineering Inc. Details, Company Type, Blood Product Area Served and Its Competitors
Table 104. Hualan Biological Engineering Inc. Blood Product Product Offered
Table 105. Hualan Biological Engineering Inc. Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Hualan Biological Engineering Inc. Main Business
Table 107. Hualan Biological Engineering Inc. Latest Developments
Table 108. Beijing Tiantan Biological Products Corp Details, Company Type, Blood Product Area Served and Its Competitors
Table 109. Beijing Tiantan Biological Products Corp Blood Product Product Offered
Table 110. Beijing Tiantan Biological Products Corp Main Business
Table 111. Beijing Tiantan Biological Products Corp Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Beijing Tiantan Biological Products Corp Latest Developments
Table 113. Pacific Shuanglin Details, Company Type, Blood Product Area Served and Its Competitors
Table 114. Pacific Shuanglin Blood Product Product Offered
Table 115. Pacific Shuanglin Main Business
Table 116. Pacific Shuanglin Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Pacific Shuanglin Latest Developments
Table 118. Boya Bio-Pharmaceutical Details, Company Type, Blood Product Area Served and Its Competitors
Table 119. Boya Bio-Pharmaceutical Blood Product Product Offered
Table 120. Boya Bio-Pharmaceutical Main Business
Table 121. Boya Bio-Pharmaceutical Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Boya Bio-Pharmaceutical Latest Developments
Table 123. Paisi Feike Biology Pharmacy Co., Ltd. Details, Company Type, Blood Product Area Served and Its Competitors
Table 124. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Product Offered
Table 125. Paisi Feike Biology Pharmacy Co., Ltd. Main Business
Table 126. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Paisi Feike Biology Pharmacy Co., Ltd. Latest Developments
Table 128. Xinjiang Deyuan Bioengineering Details, Company Type, Blood Product Area Served and Its Competitors
Table 129. Xinjiang Deyuan Bioengineering Blood Product Product Offered
Table 130. Xinjiang Deyuan Bioengineering Main Business
Table 131. Xinjiang Deyuan Bioengineering Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Xinjiang Deyuan Bioengineering Latest Developments
Table 133. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Details, Company Type, Blood Product Area Served and Its Competitors
Table 134. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Product Offered
Table 135. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business
Table 136. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
Table 138. Shenzhen Weiguang Details, Company Type, Blood Product Area Served and Its Competitors
Table 139. Shenzhen Weiguang Blood Product Product Offered
Table 140. Shenzhen Weiguang Main Business
Table 141. Shenzhen Weiguang Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Shenzhen Weiguang Latest Developments
Table 143. Shanxi Kangbao Details, Company Type, Blood Product Area Served and Its Competitors
Table 144. Shanxi Kangbao Blood Product Product Offered
Table 145. Shanxi Kangbao Main Business
Table 146. Shanxi Kangbao Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Shanxi Kangbao Latest Developments
Table 148. Nanyue Biopharming Corporation Ltd Details, Company Type, Blood Product Area Served and Its Competitors
Table 149. Nanyue Biopharming Corporation Ltd Blood Product Product Offered
Table 150. Nanyue Biopharming Corporation Ltd Main Business
Table 151. Nanyue Biopharming Corporation Ltd Blood Product Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Nanyue Biopharming Corporation Ltd Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Anupriya Singh

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (23 January, 2025)
Notify To Team (23 January, 2025)
Report updation (24 January, 2025)
Report Quality Check (24 January, 2025)
Report Dispatch (25 January, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Blood Product Market Growth (Status and Outlook) 2024-2030

2024